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Abstract: Low Protein Kinase C zeta (PKCζ) levels in cord blood T cells (CBTC) have been shown to
correlate with the development of allergic sensitization in childhood. However, little is known about
the mechanisms responsible. We have examined the relationship between the expression of different
levels of PKCζ in CBTC and their development into mature T cell cytokine producers that relate to
allergy or anti-allergy promoting cells. Maturation of naïve CBTC was initiated with anti-CD3/-CD28
antibodies and recombinant human interleukin-2 (rhIL-2). To stimulate lymphocyte proliferation and
cytokine production the cells were treated with Phytohaemagglutinin (PHA) and Phorbol myristate
acetate (PMA). Irrespective of the PKCζ levels expressed, immature CBTC showed no difference in
lymphocyte proliferation and the production of T helper 2 (Th2) cytokine interleukin-4 (IL-4) and
Th1 cytokine, interferon-gamma (IFN-γ), and influenced neither their maturation from CD45RA+ to
CD45RO+ cells nor cell viability/apoptosis. However, upon maturation the low PKCζ expressing
cells produced low levels of the Th1 cytokines, IFN-γ, IL-2 and tumour necrosis factor-alpha (TNF),
no changes to levels of the Th2 cytokines, IL-4, IL-5 and IL-13, and an increase in the Th9 cytokine,
IL-9. Other cytokines, lymphotoxin-α (LT-α), IL-10, IL-17, IL-21, IL-22 and Transforming growth
factor-beta (TGF-β) were not significantly different. The findings support the view that low CBTC
PKCζ levels relate to the increased risk of developing allergic diseases.
Keywords: cord blood T cells; T cell maturation; Th1 and Th2 subsets; PKCζ; cytokines; allergy
1. Introduction
In developed countries, about 40% of children develop allergic sensitization, resulting
in symptomatic disease [1]. With similar trends now evident in developing countries, the
disease burden is likely to further escalate [2]. There is therefore an increasing need for
validation of biomarkers which identify those at risk of developing allergy and approaches
to modulation of immune responses away from allergy promoting response. While T helper
1 (Th1) and regulatory T cells play protective roles in allergy, Th2, Th9 and Th22 promote
allergy. Th1 lymphocytes produce Interferon-gamma (IFN-γ) while Th2 cells are mainly
producers of interleukin 4 (IL-4), IL-5 and IL-13, which is a hallmark of atopy or allergy.
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IL-4 promotes Th2 development and differentiation [3], immunoglobulin class switch to
Immunoglobulin E (IgE) in B cells, and high-affinity IgE receptor (FcεR1) expression on
mast cells. IL-5 is imperative in the survival, activation, development, and differentiation
of mast cells and eosinophils and increases basophils degranulation. IL-13, which shares
some role with IL-4, also regulates immunoglobulin class switch to IgE and promotes
eosinophil trafficking to mucosal sites. Th9 cells are the main producers of IL-9, although
it is debatable whether these are Th9 per se or Th2 [4–6], with similar roles as Th2 cell
cytokines, promoting the development of allergic asthma [5–16]. This subset develops
in the presence of IL-4 and Transforming growth factor-beta (TGF-β) and is inhibited
by IFN-γ [17–19]. IL-9 increases IgE expression, causing Bronchial Hyperresponsiveness
in inhaled methacholine-induced asthma [20,21] and enhanced mucus production by
epithelial cells [22]. It is also involved in accumulation, survival, growth, proliferation
activation and differentiation of mast cells [9,23,24]. In mast cells, it increases expression of
proteases and the FcεRIα [9,25]. IL-9 also plays a role in airway eosinophilia and promotes
eosinophil survival and differentiation and IL-5Receptor (IL-5R) expression [21,26,27].
In contrast, the Th1 cytokine IFN-γ is inhibitory toward development of Th2 and Th9
cells [28–30].
We have previously demonstrated that cord blood T cells (CBTC) may display low
levels of different Protein Kinase C (PKC) isozymes [31–35] which normalizes during
maturation [36] but most interesting was that the levels of PKCζ in immature CBTC
correlated with the risk of developing allergic diseases [3]. Babies found to have low
expression of PKCζ in their CBTC were at high risk of developing allergy [3]. Examination
of development of sensitization found that a PKCζ level of <62% could predict allergy
development with an accuracy of 71%, sensitivity of 80% and 63% specificity [33,34].
Further support for the importance of PKCζ levels in CBTC as a potential determinant
of allergy control comes from in vitro culture models of CBTC maturation. These studies
suggest PKCζ levels may influence the maturation of T cells into Th cells with a propensity
to produce either Th1 or Th2 cytokines, such that higher levels of PKCζ appear to skew
these responses towards Th1 IFN-γ production. In addition, supplementation of women
during pregnancy with ω-3 polyunsaturated fatty acids (fish oil) was associated with
an increase in expression of PKCζ in CBTC, with associated protection against allergic
sensitization in the first year of life [33,34].
Despite these findings, we understand very little about factors and pathways that
alter naïve CBTC maturation towards Th1 or Th2 or in other subsets, propensity. Our
study seeks to further elucidate these pathways to facilitate early detection that may assist
interventions to reduce the epidemic rates of allergic disease through primary prevention.
Specifically, here we investigated the relationship between naïve CBTC PKCζ levels and
their development to Th1 or Th2 cytokine producers and extended this question to other
cytokines which protect against or promote allergy, such as IL-9, IL-17 and IL-10. Since
previous studies showed an important role for PKCζ in protection against apoptosis in the
human T cell line, Jurkat cells [37], our studies extend to determine whether deficient/low
levels of PKCζ influence survival of T cells during this maturation.
2. Results
2.1. The Levels of PKCζ in Immature CBTC Does Not Affect Cytokine Pattern Expressed and
Lymphoproliferation
In all the following studies, the PKCζ levels were measured by intracellular staining
by flow cytometry using fluorochrome-tagged monoclonal antibody. To define T cells
expressing low and high PKCζ, we established the 5th (34.6%) percentile from a cohort of
normal adult volunteers (Figure 1a). Those expressing PKCζ levels below the 5th percentile
were considered to be low and above the cut off as high (Figure 1a). The data also show
that there is a significant difference in the level of PKCζ between CBTC and adult blood T
cells (Figure 1a).
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Figure 1. Comparison of proliferation and cytokine production in naïve cord blood T cells (CBTC) in Protein Kinase C zeta 
(PKCζ) low or high group. (a) Comparison of PKCζ between cord blood (CB) and adult blood (AB) T cells, n = 24 for each 
AB or CB. (b) Shows lymphoproliferation as a Stimulation index (SI) and disintegrations per minute (DPM) in 3H-thymi-
dine pulsed cultures stimulated with Phytohaemagglutinin (PHA) and Phorbol myristate acetate (PMA) (c) Purified CBCTs 
were stained with Carboxyfluorescein succinimidyl ester (CFSE) dye and stimulated with immobilized anti-CD3/-CD28 
antibodies for 3 days. Gating and representative histogram for CFSE dilution after exclusion of doublets and dead cells. 
Overlaid histograms for stained unstimulated and unstained stimulated samples were used as control and for gating the 
non-proliferating cells and for auto-fluorescence, respectively. (d) Naïve CB CD3+ T cells were stimulated with PHA/PMA 
(18 h) and percentage of CD3+ T cells producing interleukin-4 (IL-4) and Interferon-gamma (IFN-γ) and median fluorescent 
intensity (MFI) were examined by flow cytometry assays. (e) On day 5 of CFSE stained culture (anti-CD3/-CD28), cells 
were re-stimulated with PHA/PMA (18 h) for detection of intracellular cytokine. Representative flow dot plots and data 
Figure 1. Comparison of proliferation and cytokine production in naïve cord blood T cells (CBTC) in Protein Kinase C zeta
(PKCζ) low or high group. (a) Comparison of PKCζ between cord blood (CB) and adult blood (AB) T cells, n = 24 for each
AB or CB. (b) Shows lymphoproliferation as a Stimulation index (SI) and disintegrations per minute (DPM) in 3H-thymidine
pulsed cultures stimulated with Phytohaemagglutinin (PHA) and Phorbol myristate acetate (PMA) (c) Purified CBCTs
were stained with Carboxyfluorescein succinimidyl ester (CFSE) dye and stimulated with immobilized anti-CD3/-CD28
antibodies for 3 days. Gating and representative histogram for CFSE dilution after exclusion of doublets and dead cells.
Overlaid histograms for stained unstimulated a d unstained stimulated samples were used as control and for gating the
non-proliferating cells and for auto-fluorescence, respectively. (d) Naïve CB CD3+ T cells were stimulated with PHA/PMA
(18 h) and percentage of CD3+ T cells producing interleukin-4 (IL-4) and Interferon-gamma (IFN-γ) and median fluorescent
intensity (MFI) were examined by flow cytometry assays. (e) On day 5 of CFSE stained culture (anti-CD3/-CD28), cells
were re-stimulated with PHA/PMA (18 h) for detection of intracellular cytokine. Representative flow dot plots and data for
CFSE dye dilution and IFN-γ producing cells in high and low PKCζ group. Data mean ± SD of n = 3 for of low and n = 4
high PKCζ group. ** p < 0.01. ns: not significant (Student’s t-test).
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To examine whether there was any difference in immunocompetence between the low
and high PKCζ expressing T cells, we examined the lymphocyte proliferation response
in the immature CBTC. The CBTC were stimulated with PHA/PMA, and then the incor-
poration of tritiated thymidine ([3H]-TdR) measured after 72 h of culture. The results
showed that the PKCζ low and high cells had comparable ability to proliferate (Figure 1b).
Similar results were obtained when proliferation was conducted with CBTC stimulated
with anti-CD3/-CD28 antibodies using the Carboxyfluorescein succinimidyl ester (CFSE)
assay (Figure 1c). To determine whether the levels of PKCζ expressed by the naïve CBTC
(CD45RA+/RO−) influenced cytokine production, IFN-γ and IL-4, the CBTC expressing
either low or high PKCζwere stimulated with Phytohaemagglutinin (PHA) and Phorbol
myristate acetate (PMA) for 18h and then intracellular staining was performed to identify
IFN-γ and IL-4 producing cells. The data presented in Figure 1d demonstrate that the
immature T cells produce much more IL-4 than IFN-γ. There was no difference between
low and high expressors. The findings were similar irrespective of whether we used the %
of cytokine positive T cells or the Median Fluorescence Intensity (MFI) to run comparisons
(Figure 1d). Thus, it is evident that the levels of PKCζ did not affect the predominant IL-4
production by these immature T cells.
When the cells were harvested on day 5 after maturation (anti-CD3/-CD28, without
recombinant human interleukin-2 (rhIL-2)) and stimulated with PHA/PMA (18h), those
expressing low levels of PKCζ had reduced percentage of IFN-γ producing cells compared
to samples expressing high levels of PKCζ (Figure 1e).
2.2. CBTC PKCζ Levels and T Cell Survival during Maturation
Previous studies showed an important role for PKCζ in protection against apoptosis
in the human T cell line, Jurkat cells [37]. It was therefore of interest to see if the low and
high PKCζ expressing T cells exhibited different survival rates during their maturation
in culture. The purified CBTC were matured by addition of anti-CD3/-CD28 antibodies
and rhIL-2. When the cells were analysed for levels of 7-aminoactinomycin D (7-AAD)
and Annexin V staining as the indicator of cell death and early apoptosis, respectively, we
found no difference in apoptosis and cell survival between the low and high PKCζ CBTC
during their 7 day maturation in culture (Figure 2a). The survival levels ranged between
60–85% in the PKCζ high and 55–85% in the PKCζ low samples. Thus, the levels of CBTC
PKCζ are unlikely to be controlling the rate of apoptosis or viability. Despite the differences
in PKCζ levels, the T cells showed the same level of maturation based on the expression of
CD45RO (Figure 2c).
2.3. Low PKCζ Expression Is Associated with Decreased Development towards a Th1
Cytokine Profile
The CBTC were matured by adding anti-CD3/-CD28 and rhIL-2 and cultured for
7 days. For assessing the ability to produce cytokines the matured CBTC were stimulated
with PHA-PMA. After 18 h the intracellular cytokine expression was determined using
fluorochrome tagged monoclonal antibodies. The data showed the expression of lower
levels of the Th1 cytokines, IFN-γ, IL-2 and TNF but increased levels of Th9 cytokine IL-9
in the low PKCζ CBTC group compared to the PKCζ high group. In the case of TNF,
there was no difference in the % of T cells that expressed TNF between low/high PKCζ
expressors but of the cells that expressed TNF, the PKCζ high cells had higher levels of
TNF than the low PKCζ cells. Other cytokines, lymphotoxin α (LT-α), IL-10, IL-4, IL-13,
IL-5, IL-17, IL-21, IL-22 and TGF-βwere not significantly different (Figures 3 and 4). The
data were also expressed as correlation analysis between the PKCζ levels and different
cytokines. This evaluation confirmed that expression of high levels of PKCζ by CBTC led
to the development of T cells with a Th1 skewed response/cytokine production (Figure 5,
Figure 6 and Figure S1). Correlation analyses between IFN-γ and other cytokines showed
a positive correlation with IL-2, TNF, and LT-α, and an inverse correlation with IL-9
(Figures S2–S4). Thus, as a result of high expression of PKCζ in CBTC, there is skewing
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towards Th1 cytokine-producing cells, as shown by the ratio of the IL-4:IFN-γ producing
cells (Figure 7).
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Figure 2. Comparison of viability, apoptosis, and maturation in CBTC expressing low or high levels of PKCζ during mat-
uration in culture. Purified CB CD3+ T cells were matured with anti-CD3/-CD28 and recombinant human interleukin-2 
(rhIL-2) for 7 days. (a) Representative flow dot plots and percentage CB CD3+ T cells was analyzed at indicated times and 
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Figure 2. Comparison of viability, apoptosis, and maturation in BTC expressing low or high levels of PKCζ during
maturation in culture. Purified CB CD3+ T cells were matured with anti-CD3/-CD28 and reco binant human interleukin-2
(rhIL-2) for 7 days. (a) Representative flow dot plots and percentage CB CD3+ T cells as analyzed at indicated times and
expressed as percentage of dead cells (7-aminoactinomycin D (7-AAD+) and apoptotic cells (Annexin V+). n = 3 for low
PKCζ and n = 5 for high PKCζ (b) Cell counts during maturation assay. (c) Representative dot plot for naïve and maturation
expression in CB CD3+ T cells on day seven. Data mean ± SD of n = 4 for low and n = 4 high PKCζ group. ns: not significant
(a,b): Student’s t-test, (c): one-way ANOVA with post hoc Tukey’s multiple comparisons test.
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Figure 3. Detection of Th1 and Th2 cytokine in matured and high CBTC. Purified CB D3+ T cells were matured
wi h anti-CD3/-CD28 antibodies with recombi t human interleukin-2 (rhIL-2). On day seven, cells were eft unstimulated
i lated with PHA/PMA overnight. Dead cells wer exclude by gating on Fixable Viabil ty Stain 510 (FVS510)
negative population and cytokines w re analysed by flo try. Representa ive histograms and graphs for (a) Th1
and (b) Th2 cytokines in PKCζ low and high samples sho e gating for the analysis of % positive cells for respective
cytokin s percentage and their . Shaded and empty histograms represent unstimulated and s imulated a ples stained
with a cytokine-sp cific antibody. Graphs re resent the means ± SD of n = 6 for low and 5 for high. * p < 0.05. ns: not
significant. (Stu t’ t-t st).
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* p < 0.05, ** p < 0.01. ns: not significant. Correlations w re performed using t t -t iled Pearson correlation coefficient.
Int. J. Mol. Sci. 2021, 22, 4907 9 of 16
Int. J. Mol. Sci. 2021, 22, x FOR PEER REVIEW 9 of 17 
 
 
Figure 6. Correlation of PKCζ expression with Th2/Th9 cytokines. Data from Figure 4 were subjected to correlation anal-
ysis. The first column represents the Pearson correlation of PKCζ (MFI) with representative cytokines (percentage of CD3+ 
T cells for each cytokine) and the second column represents the MFI of the positive gated cells. ** p < 0.01, *** p < 0.001. ns: 
not significant. Correlations were performed using the two-tailed Pearson correlation coefficient. 
Figure 6. Correlation of PKCζ expression with tokines. Dat from Figure 4 were subjected to correlati n an lysis.
The first lu n repres nts the P arson correlation of PKCζ (MFI) with representative cytokin s (perce tage of CD3+ T cells
for each cytokine) and the second column represents the MFI of the positive gated cells. ** p < 0.01, *** p < 0.001. ns: not
significant. Correlations ere erf r ed using the two-tailed Pearson correlation c efficient.
Int. J. Mol. Sci. 2021, 22, 4907 10 of 16Int. J. Mol. Sci. 2021, 22, x FOR PEER REVIEW 10 of 17 
 
 
Figure 7. The ratio of Th2 vs. Th1 in low vs. high PKCζ CBTC. Purified CB CD3+ T cells were overnight stimulated as in 
Figure 1 (naive T cells) and Figures 4 and5 (mature T cells). The cells were gated for total CD3+ T cells producing IL-4 and 
IFN-γ as percentage of T cells or MFI as examined by flow cytometry assays. Comparison of percentage decrease in IL-4: 
IFN-γ in mature T cells (normalized against naïve T cells) and compared between CB samples expressing low vs. high 
PKCζ. n = 3 for low and n = 4 for high PKCζ group. * p < 0.05. ns: not significant. (Student’s t-test). 
3. Discussion 
The data demonstrate that when stimulated immature CBTC produce substantially 
more IL-4 compared to IFN-γ. Previous reports have primarily used CBMC, although a 
limited number have used purified T cells to examine this question [38–41]. Our studies 
confirm and extend these findings by also showing that the deficiency in PKCζ in CBTC 
does not contribute to the decrease in IFN-γ production and not affect the T lymphocyte 
proliferation responses of the immature T cells. Examination of T cells during maturation 
also showed that the decreased expression of PKCζ was not associated with loss of cell 
viability and apoptosis, although in the Jurkat T cell line PKCζ was found to protect 
against apoptosis [37]. 
The different levels of PKCζ expressed in CBTC did not affect either the maturation 
of the CBTC over the 7-day culture period, i.e., cells progressing from a CD45RA+/RO- 
phenotype to CD45RA-/RO+ phenotype or T cell growth. The main difference observed 
was a correlation with skewing the response of the matured T cells—with a propensity to 
give rise to either a Th1 (in the PKCζ high cells) or Th9 skewed response (in the PKCζ low 
cells). Examination of matured T cell cytokine responses showed that those derived from 
low PKCζ expressing CBTC produced lower amounts of Th1 cytokines, IFN-γ, IL-2, TNF 
but higher Th9 cytokine, IL-9, seen as either a significant increase in the number of cyto-
kine-producing cells and/or in MFI. Pearson correlation analysis of the PKCζ levels 
against the production of the different cytokines supported the PKCζ level dependency 
of the Th1 and Th9 responses. This cytokine pattern further supported the finding by 
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Figure 7. The ratio of Th2 vs. Th1 in low vs. high PKCζ CBTC. Purified CB CD3+ T cells were
overnight stimulated as in Figure 1 (naive T cells) and Figures 4 and 5 (mature T cells). The cells were
gated for total CD3+ T cells producing IL-4 and IFN-γ as percentage of T cells or MFI as examined
by flow cytometry assays. Comparison of percentage decrease in IL-4: IFN-γ in mature T cells
(normalized against naïve T cells) and compared between CB samples expressing low vs. high PKCζ.
n = 3 for low and n = 4 for high PKCζ group. * p < 0.05. ns: not significant. (Student’s t-test).
3. Discussion
The data demonstrate that when stimulated immature CBTC produce substantially
more IL-4 compared to IFN-γ. Previous reports have primarily used CBMC, although a
limited number have used purified T cells to examine this question [38–41]. Our studies
confirm and extend these findings by also showing that the deficiency in PKCζ in CBTC
does not contribute to the decrease in IFN-γ production and not affect the T lymphocyte
proliferati n responses of th immature T cells. Examination of T cells during m tura ion
also showed that the decreased expression of PKCζ was not associated with loss of cell
viability and apoptosis, although in the Jurkat T cell line PKCζwas found to protect against
apoptosis [37].
The different levels of PKCζ expressed in CBTC did not affect either the maturation
of the CBTC over the 7-day culture period, i.e., cells progressing from a CD45RA+/RO−
phenotype to CD45RA−/RO+ phenotype or T cell growth. The main difference observed
was a correlation with skewing the response of the matured T cells—with a propensity
to give rise to either a Th1 (in the PKCζ high cells) or Th9 skewed response (in the PKCζ
low cells). Examination f ma ured T cell cytokine responses showed that those derived
from low PKCζ xpr ssing CBTC produced lower amount of Th1 cytokines, IFN-γ, IL-2,
TNF but higher Th9 cytokine, IL-9, seen as either a significant increase in the number of
cytokine-producing cells and/or in MFI. Pearson correlation analysis of the PKCζ levels
against the production of the different cytokines supported the PKCζ level dependency
of the Th1 and Th9 responses. This cytokine pattern further supported the finding by
showing that there was a strong and significant positive correlation between the levels of
IFN-γ expression and each of the other Th1 cytokines, IL-2 and TNF. Although we did not
find a correlation with LT-α, this is not surprising since this is fully expressed in immature
CBTC. As expected, there was a negative correlation between IFN-γ and the Th9 cytokine,
IL-9. However, no sign ficant correlation was found with IL-13, IL-5 and IL-4. However,
it was evident that the PKCζ levels in immature CBTC correlated with a decrease in the
IL-4:IFN-γ ratio following their maturation. These findings contrast with our previous
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findings that knocking out PKCζ from CBTC leads to development towards Th2, IL-13
producing phenotype, suggesting that there may be a thresh hold PKCζ level, below
which, may promote the Th2 phenotype development [35]. Never-the-less collectively the
findings suggest that there may be an intricate network operating in the mechanism of T
cell development to acquire specific functional responses. Whether an increase in sample
numbers/statistical power modifies the results, remains to be determined.
The results reveal, for the first time, that CBTC expressing high PKCζ levels mature
to display Th1 capabilities such as the production of IFN-γ, IL-2 and TNF but low Th9
cytokine IL-9. The levels of PKCζ did not influence the development of cells expressing IL-
4, IL-5 or IL-13. Furthermore, CBTC PKCζ levels did not correlate with the development of
regulatory cytokines IL-10 and TGF-β producing T cells or cells producing the inflammatory
cytokines, IL-17, IL-21 and IL-22. The finding suggests the existence of an influence by the
PKCζ levels in naïve CBTC and development of allergen sensitization, due primarily to its
influence on the Th1 arm of the immune response and also on Th cells, producing IL-9. Our
findings thus suggest that the most likely protective effects of higher expression of PKCζ
to allergen sensitization [33] are due to CBTC maturation towards Th1 IFN-γ producing
cells with a decrease in Th9, IL-9 producing cells. This supports the view that PKCζ levels
measured in CBTC are relevant to allergy risk in later life and that modulating the levels
through nutrients such asω-3 polyunsaturated fatty acids may be of benefit in those at risk
of developing allergic diseases.
4. Materials and Methods
4.1. Reagents
The mouse monoclonal IgG2aκ phycoerythrin (PE)-conjugated PKCζ isozyme anti-
body (clone H-1, and previously validated by our laboratory [32]) was purchased from
Santa Cruz Biotechnology (Dallas, TX, USA). The corresponding isotype control was
purchased from BD (Franklin Lakes, NJ, USA). RPMI 1640 tissue culture medium (Sigma-
Aldrich Cat# R0883), X-VIVO 15 medium (04418Q, Lonza, BSL, Switzerland), foetal calf
serum (FCS) and L-glutamine were purchased from SAFC Biosciences (Lenexa, KS, USA).
PHA, PMA and human AB serum were from Sigma Aldrich (St. Louis, MI, USA), whilst
rhIL-2 was purchased from PeproTech (Rocky Hill, NJ, USA).
4.2. Ethics Statement
The procurement of human blood and all experimental procedures were approved by
the Human Research Ethics Committee of the Women’s and Children’s Health Network
(WCHN), Adelaide, South Australia, in accordance to The National Statement on Ethical
Conduct in Human Research (2007, updated 2018) (National Health and Medical Research
Council Act 1992). Venous blood was collected from healthy adult volunteers with their
informed consent and umbilical CB from healthy neonates with informed consent from
pregnant women undergoing elective caesarean section.
4.3. Preparation of Cord Blood and Peripheral Blood Mononuclear Cells
Mononuclear cells (MC) were isolated from cord blood (CB) and adult peripheral blood
(PB) by centrifugation on Ficoll® Paque Plus media (GE Healthcare, Uppsala, Sweden)
according to the manufacturer’s protocol. The interphase layer containing MC was har-
vested and then washed in RPMI-1640 medium supplemented with 2 mmol/L L-glutamine,
100 U/mL penicillin, 100 µg/mL streptomycin and 10% foetal calf serum (complete media).
The CBMC or PBMC were cryopreserved at 5–10 × 106 in 90% FCS and 10% DMSO, as
previously described, for later functional analysis [32].
4.4. Isolation of T Cells
T cell isolation was performed using EasySep™ Human CD3+ T cell Isolation Kit (Stem
Cell Technologies, Vancouver, Canada) by negative isolation, according to manufacturer
protocols. Cryopreserved CBMC were rapidly thawed in a 37 ◦C water bath and washed in
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Phosphate-buffered saline (PBS) supplemented with 2%FCS and 1 mM EDTA (separation
buffer). Viability was assessed by Trypan blue dye exclusion assay and found to be
approximately 90%. Cells were resuspended in 0.25 to 2 mL of separation buffer, in 5 mL
(12 × 75 mm) polystyrene round-bottom tubes (Corning, Cat #352058), maintaining a
cell concentration of 5 × 107 cells/mL. EasySep™ Human CD3+ T Cell Isolation Cocktail
was added at 50 µL/mL of sample and incubated for 5 min. EasySep™ Dextran Rapid
Spheres™ (50 µL/mL) were added and samples were reconstituted to 2.5 mL separation
buffer. The T cells were retrieved using an EasySep™ Magnet (STEMCELL Technologies,
Cat #18000), with purity consistently greater than 97%.
4.5. CBTC Maturation
Cord blood T cells were matured using an anti-CD3 and anti-CD28 co-stimulation
method. Briefly, anti-CD3 antibodies (OKT3, Abcam, Cambridge, UK) were immobilised
in 24 well plates by adding 2.5 µg/mL in Hank’s Balanced Salt Solution (HBSS) into each
well, and refrigerating overnight or incubated for 3 h at 37 ◦C, and then washed with HBSS.
At initiation of culture, anti-CD28 antibodies (Clone CD28.2, eBiosciences, San Diego, CA,
USA) were added to a final concentration of 1 µg/mL with 1 × 106 CBTC to each well in a
total volume of 1 mL. After three days of culture, cells were counted and reseeded at 1 ×
106/mL with the addition of rhIL-2 (10 ng/mL), and this process was repeated on day 5.
On day 7 the CD45RA/RO surface expression was measured by flow cytometry.
4.6. Apoptosis and Cell Viability Assays
Early and late apoptosis was ascertained using Annexin V and 7-AAD, respectively.
The staining panel is described in Table 1. At the indicated time points 2 × 105 cells were
harvested and washed in 1 mL of Annexin V Binding buffer (10 mM HEPES (pH 7.4),
0.14 M NaCl, 0.25 mM CaCl2 and 0.5% BSA), incubated with Fluorescein isothiocyanate
(FITC)-conjugated Annexin V for 20 min at room temperature (RT) in the dark. After two
washes with Annexin V Binding buffer, samples were stained with 7-AAD for 5 min at RT
and analysed by flow cytometry.
Table 1. Staining panel for apoptotic or dead cells.
Target/Antibody Fluorochrome Clone Catalogue Company
Annexin V FITC 556420 BD
Anti-CD3 APC-CY7 SK7(Leu-4) 557832 BD
- 7-AAD 51-68981E BD
4.7. T Cell Proliferation Assays
Radiometric method: Briefly, in 96-well round bottom plates, T cells were added at
2 × 105/well in RPMI/2.5% AB serum with or without PHA (2 µg/mL) or PMA (10 ng/mL)
in triplicate, and incubated at 37 ◦C, 95% humidity and 5% CO2 for 72 h. Cells were
pulsed with 1 µCi [3H]-thymidine 6 h prior to harvesting onto glass filter paper using a
Titertek cell harvester. These were then added into vials with liquid scintillation cocktail
(PerkinElmer) and processed in a β-scintilation counter (Wallac 1409 Liquid Scintillation
Counter, PerkinElmer). Data are presented as a stimulation index (SI) of disintegrations
per minute (DPM) in stimulated/DPM in unstimulated.
Carboxyfluorescein succinimidyl ester (CFSE) based cell division: T cells at 2 × 106/mL
were labelled with 1 µM of CFSE (CellTrace™ CFSE Cell Proliferation Kit, Invitrogen, Cat#
C34554) in PBS without FCS. Following a 5 min incubation in the dark, the cells were
washed with complete media and resuspended in X-VIVO 15 medium supplemented
with 2 mmol/L L-glutamine, 100 U/mL penicillin, 100 µg/mL streptomycin and 10%
FCS (complete X-VIVO media). Viability was examined by trypan blue dye exclusion.
Proliferation was examined in T cells treated without or with anti-CD3/-CD28 antibodies
in 96 well plates at 2 × 105/well (as in Section 4.5), in complete X-VIVO/AB serum media.
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Cells were assessed on day three on a BD FACSCanto, using the FL-1/FITC channel to
detect reduction in CFSE with cell division.
4.8. T Cell Maturation
To ascertain T cell maturation, CD45RA and CD45RO expression was examined at
various time-points of T cell culture. For each time-point, 2 × 105 cells were harvested
and resuspended in 50 µL PBS/1% FCS (wash solution), followed by incubating with a
cell surface staining antibody panel (as described in Table 2) for 20 min at RT in the dark.
Following two washes in wash solution, the samples were acquired on a BD FACSCanto
and analysed using FlowJo v10.1 (Ashland, OR, USA). Lymphocytes were gated based on
their high CD45 expression and were further gated on CD3+ T cells to examine surface
expression of CD45RA and CD45RO.
Table 2. Staining panel for naïve/memory subsets in human CBTC.
Antibody Fluorochrome Clone Catalogue Company
Anti-CD45RA FITC HI100 555488 BD
Anti-CD45RO PE UCHL1 555493 BD
Anti-CD3 PE-CY5 HIT3a 555341 BD
Anti-CD45 APC-H7 2D1 641399 BD
4.9. Detection of Intracellular Cytokines
Intracellular cytokines were measured in stimulated mature or immature T cells, using
the BD Cytofix/Cytoperm™ Plus Permeabilization Kit with GolgiPlug. Briefly, 1 × 106
cells/mL in RPMI/2.5% AB serum were stimulated with 50 nM PMA and 2 µg/mL PHA
in the presence of Brefeldin A, and incubated at 37 ◦C/5%CO2 for 16–20 h. Cells were
then washed in wash solution and resuspended in 200 µL of wash solution for surface
staining with anti-CD3 PE-Cy5 (HIT3a), and anti-CD45 APC-H7 (2D1), for 15 to 20 min
at RT in the dark. The cells were stained with the BD Horizon™ Fixable Viability Stain
510 (FVS510) Stock Solution (1:1000) in sodium azide- and protein-free PBS. At the end of
15 min incubation, cells were washed twice with 2 mL of wash solution. The cells were
then fixed with 250 µL BD Cytofix/CytoPerm™ Fixation and Permeabilization Solution for
20 min at RT in the dark, and then permeabilized with 1 mL of BD Perm/Wash for 10 min at
RT in the dark. A selected panel of antibodies for intracellular cytokine detection was then
added to the cells (see Tables 3–5) and then incubated for 30 min at RT in the dark. After
two washes with BD Perm/Wash, the samples were acquired on either a FACSCanto or
FACSCanto II, as appropriate. Data analysis was performed using FlowJo v10.1. Cytokine
expression and percentage positive cells were analysed after exclusion of doublets and
dead cells by gating on FVS510−cell population.
Table 3. Intracellular staining of IL-4 and IFN-γ cytokines in T cells.
Antibody Fluorochrome Clone Catalogue Company
Anti-IFN-γ FITC 4S.B3 554551 BD
Anti-IL-4 PE 8D4-8 12-7049-42 eBioscience
Anti-CD3 PE-CY5 HIT3a 555341 BD
Anti-CD45 APC-H7 2D1 641399 BD
Mouse-IgG1k FITC MOPC-21 555748 BD
Mouse-IgG1k PE MOPC-21 556650 BD
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Table 4. Intracellular cytokines cocktail # 1 for T helper subsets.
Antibody Fluorochrome Clone Catalogue Company
Anti-IL-2 BV421 5344.111 562914 BD
Anti-IL-10 AF488 JES3-9D7 501413 BioLegend
Anti-LT-α PE 359-81-11 554556 BD
Anti-IL-17A PerCP-Cy™5.5 N49-653 560799 BD
Anti-TGF-βI PE/Cy7 TW4-2F8 349610 BioLegend
Anti-TNF APC MAb11 554514 BD
Anti-IFN-γ APC/CY7 4S.B3 502530 BioLegend
BV510(viability
stain) - 564406 BD
Table 5. Intracellular cytokines cocktail # 2 for T helper subsets.
Target Fluorochrome Clone Catalogue Company
Anti-IL-13 BV421 JES10-5A2 563580 BD
Anti-IL-4 FITC MP4-25D2 562047 BD
Anti-IL-21 PE 3A3-N2.1 562042 BD
Anti-IL-9 PerCP-Cy™5.5 MH9A3 561461 BD
Anti-IL-5 APC TRFK5 562048 BD
Anti-IL-22 PE/Cy7 2G12A41 366707 BioLegend
Anti-IFN-γ APC/CY7 4S.B3 502530 BioLegend
BV510 (viability
stain) - 564406 BD
4.10. Statistical Analysis
Statistical comparisons were performed using one-way ANOVA with post hoc Tukey’s
multiple comparisons test, or Student’s t-testing. Correlations were performed using the
two-tailed Pearson correlation coefficient. All statistical analyses were performed using
Graphpad Prism v9 (GraphPad Software, La Jolla, CA, USA). A p-value of <0.05 was
considered statistically significant for all analyses.
Supplementary Materials: Supplementary Materials can be found at https://www.mdpi.com/
article/10.3390/ijms22094907/s1.
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Abbreviations
CBTC cord blood T cells
CBMC CB mononuclear cells
PBMC peripheral blood MC
AB adult blood
PKC Protein Kinase C
PHA Phytohaemagglutinin
PMA Phorbol myristate acetate
IFN-γ Interferon-gamma
rhIL-2 recombinant human interleukin 2
TNF tumour necrosis factor-alpha
LT-α Lymphotoxin α
TGF-β Transforming growth factor-beta
CFSE carboxyfluorescein succinimidyl ester




FcεR1 High-affinity IgE receptor
RPMI 1640 Roswell Park Memorial Institute 1640
IL-5R IL-5 receptor
FCS foetal calf serum
References
1. Prescott, S.L.; Tang, M.L. The Australasian Society of Clinical Immunology and Allergy position statement: Summary of allergy
prevention in children. Med. J. Aust. 2005, 182, 464–467. [CrossRef]
2. Loh, W.; Tang, M.L.K. The epidemiology of food allergy in the global context. Int. J. Environ. Res. Public Health 2018, 15, 2043.
[CrossRef]
3. Chu, D.K.; Mohammed-Ali, Z.; Jiménez-Saiz, R.; Walker, T.D.; Goncharova, S.; Llop-Guevara, A.; Kong, J.; Gordon, M.E.; Barra,
N.G.; Gillgrass, A.E.; et al. T helper cell IL-4 drives intestinal Th2 priming to oral peanut antigen, under the control of OX40L and
independent of innate-like lymphocytes. Mucosal. Immunol. 2014, 7, 1395–1404. [CrossRef]
4. Angkasekwinai, P.; Dong, C. IL-9-producing T cells: Potential players in allergy and cancer. Nat. Rev. Immunol. 2021, 21, 37–48.
[CrossRef]
5. Goswami, R.; Kaplan, M.H. A brief history of IL-9. J. Immunol. 2011, 186, 3283–3288. [CrossRef] [PubMed]
6. Angkasekwinai, P. Allergic inflammation and atopic disease: Role of Th9 cells. In Th9 Cells: Methods and Protocols; Goswami, R.,
Ed.; Springer: New York, NY, USA, 2017; pp. 189–199.
7. Renauld, J.-C. New insights into the role of cytokines in asthma. J. Clin. Pathol. 2001, 54, 577–589. [CrossRef] [PubMed]
8. Hauber, H.P.; Bergeron, C.; Hamid, Q. IL-9 in allergic inflammation. Int. Arch. Allergy Immunol. 2004, 134, 79–87. [CrossRef]
9. Soussi-Gounni, A.; Kontolemos, M.; Hamid, Q. Role of IL-9 in the pathophysiology of allergic diseases. J. Allergy Clin. Immunol.
2001, 107, 575–582. [CrossRef] [PubMed]
10. Coquet, J.M. A singular role for interleukin-9 in the development of asthma. Sci. Immunol. 2020, 5. [CrossRef]
11. Koch, S.; Sopel, N.; Finotto, S. Th9 and other IL-9-producing cells in allergic asthma. Semin. Immunopathol. 2017, 39, 55–68.
[CrossRef]
12. Jones, C.P.; Gregory, L.G.; Causton, B.; Campbell, G.A.; Lloyd, C.M. Activin A and TGF-β promote Th9 cell–mediated pulmonary
allergic pathology. J. Allergy Clin. Immunol. 2012, 129, 1000–1010.e3. [CrossRef] [PubMed]
13. Shik, D.; Tomar, S.; Lee, J.B.; Chen, C.Y.; Smith, A.; Wang, Y.H. IL-9-producing cells in the development of IgE-mediated food
allergy. Semin. Immunopathol. 2017, 39, 69–77. [CrossRef] [PubMed]
14. Xie, J.; Lotoski, L.C.; Chooniedass, R.; Su, R.C.; Simons, F.E.; Liem, J.; Becker, A.B.; Uzonna, J.; HayGlass, K.T. Elevated
antigen-driven IL-9 responses are prominent in peanut allergic humans. PLoS ONE 2012, 7, e45377. [CrossRef] [PubMed]
15. Brough, H.A.; Cousins, D.J.; Munteanu, A.; Wong, Y.F.; Sudra, A.; Makinson, K.; Stephens, A.C.; Arno, M.; Ciortuz, L.; Lack, G.;
et al. IL-9 is a key component of memory Th cell peanut-specific responses from children with peanut allergy. J. Allergy Clin.
Immunol. 2014, 134, 1329–1338.e10. [CrossRef] [PubMed]
16. Jia, L.; Wang, Y.; Li, J.; Li, S.; Zhang, Y.; Shen, J.; Tan, W.; Wu, C. Detection of IL-9 producing T cells in the PBMCs of allergic
asthmatic patients. BMC Immunol. 2017, 18, 38. [CrossRef]
17. Schmitt, E.; Germann, T.; Goedert, S.; Hoehn, P.; Huels, C.; Koelsch, S.; Kühn, R.; Müller, W.; Palm, N.; Rüde, E. IL-9 production
of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by
IFN-gamma. J. Immunol. 1994, 153, 3989–3996. [PubMed]
Int. J. Mol. Sci. 2021, 22, 4907 16 of 16
18. Dardalhon, V.; Awasthi, A.; Kwon, H.; Galileos, G.; Gao, W.; Sobel, R.A.; Mitsdoerffer, M.; Strom, T.B.; Elyaman, W.; Ho, I.C.; et al.
IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3− effector T cells. Nat.
Immunol. 2008, 9, 1347–1355. [CrossRef] [PubMed]
19. Veldhoen, M.; Uyttenhove, C.; van Snick, J.; Helmby, H.; Westendorf, A.; Buer, J.; Martin, B.; Wilhelm, C.; Stockinger, B.
Transforming growth factor-beta ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing
subset. Nat. Immunol. 2008, 9, 1341–1346. [CrossRef] [PubMed]
20. Petit-Frere, C.; Dugas, B.; Braquet, P.; Mencia-Huerta, J. Interleukin-9 potentiates the interleukin-4-induced IgE and IgG1 release
from murine B lymphocytes. Immunology 1993, 79, 146.
21. Temann, U.A.; Geba, G.P.; Rankin, J.A.; Flavell, R.A. Expression of interleukin 9 in the lungs of transgenic mice causes airway
inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J. Exp. Med. 1998, 188, 1307–1320. [CrossRef]
22. Louahed, J.; Toda, M.; Jen, J.; Hamid, Q.; Renauld, J.-C.; Levitt, R.C.; Nicolaides, N.C. Interleukin-9 upregulates mucus expression
in the airways. Am. J. Respir. Cell Mol. Biol. 2000, 22, 649–656. [CrossRef] [PubMed]
23. Matsuzawa, S.; Sakashita, K.; Kinoshita, T.; Ito, S.; Yamashita, T.; Koike, K. IL-9 enhances the growth of human mast cell
progenitors under stimulation with stem cell factor. J. Immunol. 2003, 170, 3461–3467. [CrossRef]
24. Sehra, S.; Yao, W.; Nguyen, E.T.; Glosson-Byers, N.L.; Akhtar, N.; Zhou, B.; Kaplan, M.H. Th9 cells are required for tissue mast
cell accumulation during allergic inflammation. J. Allergy Clin. Immunol. 2015, 136, 433–440.e1. [CrossRef]
25. Louahed, J.; Kermouni, A.; Van Snick, J.; Renauld, J.-C. IL-9 induces expression of granzymes and high-affinity IgE receptor in
murine T helper clones. J. Immunol. 1995, 154, 5061–5070.
26. Dong, Q.; Louahed, J.; Vink, A.; Sullivan, C.D.; Messler, C.J.; Zhou, Y.; Haczku, A.; Huaux, F.; Arras, M.; Holroyd, K.J. IL-9
induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice. Eur. J. Immunol. 1999,
29, 2130–2139. [CrossRef]
27. Gounni, A.S.; Gregory, B.; Nutku, E.; Aris, F.; Latifa, K.; Minshall, E.; North, J.; Tavernier, J.; Levit, R.; Nicolaides, N. Interleukin-9
enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils. Blood J. Am. Soc. Hematol. 2000,
96, 2163–2171.
28. Stone, K.D.; Prussin, C.; Metcalfe, D.D. IgE, mast cells, basophils, and eosinophils. J. Allergy Clin. Immunol. 2010, 125, S73–S80.
[CrossRef] [PubMed]
29. Kumar, R.K.; Herbert, C.; Yang, M.; Koskinen, A.M.; McKenzie, A.N.; Foster, P.S. Role of interleukin-13 in eosinophil accumulation
and airway remodelling in a mouse model of chronic asthma. Clin. Exp. Allergy 2002, 32, 1104–1111. [CrossRef]
30. Gour, N.; Wills-Karp, M. IL-4 and IL-13 signaling in allergic airway disease. Cytokine 2015, 75, 68–78. [CrossRef] [PubMed]
31. Hii, C.S.; Costabile, M.; Mayne, G.C.; Der, C.J.; Murray, A.W.; Ferrante, A. Selective deficiency in protein kinase C isoenzyme
expression and inadequacy in mitogen-activated protein kinase activation in cord blood T cells. Biochem. J. 2003, 370, 497–503.
[CrossRef] [PubMed]
32. Perveen, K.; Quach, A.; McPhee, A.; Prescott, S.L.; Barry, S.C.; Hii, C.S.; Ferrante, A. Validation of monoclonal antiPKC isozyme
antibodies for flow cytometry analyses in human T cell subsets and expression in cord blood T cells. Sci. Rep. 2019, 9, 9263.
[CrossRef] [PubMed]
33. Prescott, S.L.; Irvine, J.; Dunstan, J.A.; Hii, C.; Ferrante, A. Protein kinase C zeta: A novel protective neonatal T-cell marker that
can be upregulated by allergy prevention strategies. J. Allergy Clin. Immunol. 2007, 120, 200–206. [CrossRef] [PubMed]
34. D’Vaz, N.; Ma, Y.; Dunstan, J.A.; Lee-Pullen, T.F.; Hii, C.; Meldrum, S.; Zhang, G.; Metcalfe, J.; Ferrante, A.; Prescott, S.L. Neonatal
protein kinase C zeta expression determines the neonatal T-cell cytokine phenotype and predicts the development and severity of
infant allergic disease. Allergy 2012, 67, 1511–1518. [CrossRef]
35. Harb, H.; Irvine, J.; Amarasekera, M.; Hii, C.S.; Kesper, D.A.; Ma, Y.; D’Vaz, N.; Renz, H.; Potaczek, D.P.; Prescott, S.L.; et al. The
role of PKCζ in cord blood T-cell maturation towards Th1 cytokine profile and its epigenetic regulation by fish oil. Biosci. Rep.
2017, 37. [CrossRef]
36. Acevedo, N.; Alashkar Alhamwe, B.; Caraballo, L.; Ding, M.; Ferrante, A.; Garn, H.; Garssen, J.; Hii, C.S.; Irvine, J.; Llinás-
Caballero, K.; et al. Perinatal and early-life nutrition, epigenetics, and allergy. Nutrients 2021, 13, 724. [CrossRef]
37. Leroy, I.; de Thonel, A.; Laurent, G.; Quillet-Mary, A. Protein kinase C zeta associates with death inducing signaling complex and
regulates Fas ligand-induced apoptosis. Cell Signal. 2005, 17, 1149–1157. [CrossRef] [PubMed]
38. Rainsford, E.; Reen, D.J. Interleukin 10, produced in abundance by human newborn T cells, may be the regulator of increased
tolerance associated with cord blood stem cell transplantation. Br. J. Haematol. 2002, 116, 702–709. [CrossRef]
39. Ohshima, Y.; Yang, L.-P.; Avice, M.-N.; Kurimoto, M.; Nakajima, T.; Sergerie, M.; Demeure, C.E.; Sarfati, M.; Delespesse, G. Naive
human CD4+T cells are a major source of lymphotoxin α. J. Immunol. 1999, 162, 3790–3794.
40. Bullens, D.M.; Rafiq, K.; Kasran, A.; Van Gool, S.W.; Ceuppens, J.L. Naive human T cells can be a source of IL-4 during primary
immune responses. Clin. Exp. Immunol. 1999, 118, 384–391. [CrossRef]
41. Kloosterboer, F.M.; van Luxemburg-Heijs, S.A.; Willemze, R.; Falkenburg, J.H. Similar potential to become activated and
proliferate but differential kinetics and profiles of cytokine production of umbilical cord blood T cells and adult blood naive and
memory T cells. Hum. Immunol. 2006, 67, 874–883. [CrossRef]
